Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT01635712 |
| Title | Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Esanex Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UC Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
| Georgia Regents University Cancer Center | Augusta | Georgia | 30901 | United States | Details | |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | United States | Details | |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | United States | Details | |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37212 | United States | Details |